The COVID-19 Mobile Health Study (CMHS) (CMHS)
The COVID-19 Mobile Health Study, a Large-scale Clinical Observational Study Using nCapp
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Chunxue Bai
- Phone Number: +8618621170011
- Email: bai.chunxue@zs-hospital.sh.cn
Study Contact Backup
- Name: Dawei Yang
- Phone Number: +8613564703813
- Email: yang.dawei@zs-hospital.sh.cn
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China
- Recruiting
- Renmin Hospital of Wuhan University
-
Sub-Investigator:
- Maosong Ye
-
Contact:
- Chunxue Bai
-
Sub-Investigator:
- Xun Wang
-
Sub-Investigator:
- Jie Liu
-
Sub-Investigator:
- Chunlin Dong
-
Sub-Investigator:
- Yong Zhang
-
Principal Investigator:
- Chunxue Bai
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- High risk of COVID-19
- RT-PCR test result of SAR2-CoV-19
Exclusion Criteria:
- Not available for RT-PCR test result of SAR2-CoV-19
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Validation
|
Combined with 15 questions online, and a predicated formula to auto-diagnosis of the risk of COVID-19
|
|
Training
|
Combined with 15 questions online, and a predicated formula to auto-diagnosis of the risk of COVID-19
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of nCapp COVID-19 risk diagnostic model
Time Frame: 1 day
|
Sensitivity, specificity and area under the ROC curve of nCapp model
|
1 day
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Chunxue Bai, Shanghai Respiratory Research Institution
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CAALC-008-CMHS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.